Literature DB >> 15777859

Development and pharmacological characterization of a rat model of osteoarthritis pain.

James D Pomonis1, Jamie M Boulet, Susan L Gottshall, Steve Phillips, Rani Sellers, Tracie Bunton, Katharine Walker.   

Abstract

Osteoarthritis (OA) is an age-related joint disease characterized by degeneration of articular cartilage and is associated with chronic pain. Although several experimental models of OA have been employed to investigate the underlying etiologies of the disease, there has been relatively little investigation into development of animal models of OA to study the pain associated with the condition. In the present study, we investigated OA induced by injection of either iodoacetate or papain into the knee joint of rats, and assessed the joint degeneration with radiographic analyses and measured pain behavior using hind limb weight bearing. We found that injection of iodoacetate, but not papain, resulted in a chronic joint degeneration as measured by decreased bone mineral content and bone mineral density, necrosis of articular cartilage and osteophyte formation. These pathological changes were associated with pain that manifested as time- and concentration-dependent alterations in hind limb weight bearing. These alterations in hind limb weight bearing were reversed with morphine, but were not significantly affected by acute administration of either indomethacin or celecoxib. However, administration of 30 mg/kg celecoxib twice daily for 10 days resulted in a significant restoration of hind limb weight bearing. We conclude that the iodoacetate model of OA is a relevant animal model to study pain associated with OA, and can be used to test potential therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15777859     DOI: 10.1016/j.pain.2004.11.008

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  76 in total

1.  WAY-318068: a novel, potent and selective noradrenaline re-uptake inhibitor with activity in rodent models of pain and depression.

Authors:  G T Whiteside; J M Dwyer; J E Harrison; C E Beyer; T Cummons; L Manzino; L Mark; G H Johnston; B W Strassle; A Adedoyin; P Lu; M J Piesla; C M Pulicicchio; J C L Erve; B J Platt; Z A Hughes; K E Rogers; D C Deecher; E J Trybulski; J D Kennedy; P Zhang; L Leventhal
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

2.  Effect of low-level laser therapy on metalloproteinase MMP-2 and MMP-9 production and percentage of collagen types I and III in a papain cartilage injury model.

Authors:  Ana Carolina Araruna Alves; Regiane Albertini; Solange Almeida dos Santos; Ernesto Cesar Pinto Leal-Junior; Eduardo Santana; Andrey Jorge Serra; José Antonio Silva; Paulo de Tarso Camillo de Carvalho
Journal:  Lasers Med Sci       Date:  2013-08-29       Impact factor: 3.161

3.  In vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models.

Authors:  B B Yao; G C Hsieh; J M Frost; Y Fan; T R Garrison; A V Daza; G K Grayson; C Z Zhu; M Pai; P Chandran; A K Salyers; E J Wensink; P Honore; J P Sullivan; M J Dart; M D Meyer
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

4.  Exercise reverses pain-related weight asymmetry and differentially modulates trabecular bone microarchitecture in a rat model of osteoarthritis.

Authors:  Jim Cormier; Katherine Cone; Janell Lanpher; Abigail Kinens; Terry Henderson; Lucy Liaw; Edward J Bilsky; Tamara King; Clifford J Rosen; Glenn W Stevenson
Journal:  Life Sci       Date:  2017-05-11       Impact factor: 5.037

5.  Thirty days after anterior cruciate ligament transection is sufficient to induce signs of knee osteoarthritis in rats: pain, functional impairment, and synovial inflammation.

Authors:  Germanna M Barbosa; Jonathan E Cunha; Thiago L Russo; Thiago M Cunha; Paula A T S Castro; Francisco F B Oliveira; Fernando Q Cunha; Fernando S Ramalho; Tania F Salvini
Journal:  Inflamm Res       Date:  2020-01-31       Impact factor: 4.575

6.  Discovery of APD371: Identification of a Highly Potent and Selective CB2 Agonist for the Treatment of Chronic Pain.

Authors:  Sangdon Han; Lars Thoresen; Jae-Kyu Jung; Xiuwen Zhu; Jayant Thatte; Michelle Solomon; Ibragim Gaidarov; David J Unett; Woo Hyun Yoon; Jeremy Barden; Abu Sadeque; Amin Usmani; Chuan Chen; Graeme Semple; Andrew J Grottick; Hussein Al-Shamma; Ronald Christopher; Robert M Jones
Journal:  ACS Med Chem Lett       Date:  2017-11-30       Impact factor: 4.345

Review 7.  Evaluation of reward from pain relief.

Authors:  Edita Navratilova; Jennifer Yanhua Xie; Tamara King; Frank Porreca
Journal:  Ann N Y Acad Sci       Date:  2013-03-15       Impact factor: 5.691

8.  Descending serotonergic facilitation and the antinociceptive effects of pregabalin in a rat model of osteoarthritic pain.

Authors:  Wahida Rahman; Claudia S Bauer; Kirsty Bannister; Jean-Laurent Vonsy; Annette C Dolphin; Anthony H Dickenson
Journal:  Mol Pain       Date:  2009-08-07       Impact factor: 3.395

9.  Effect of autologous platelet-rich plasma on the repair of full-thickness articular defects in rabbits.

Authors:  Claudio Iván Serra; Carme Soler; Jose M Carrillo; Jose M Carillo; Joaquín J Sopena; J Ignacio Redondo; Ramón Cugat
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-08-24       Impact factor: 4.342

10.  A Selective Role for alpha3 Subunit Glycine Receptors in Inflammatory Pain.

Authors:  Victoria L Harvey; Alex Caley; Ulrike C Müller; Robert J Harvey; Anthony H Dickenson
Journal:  Front Mol Neurosci       Date:  2009-11-04       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.